Sign Up

ANRO

COM:ALTONEUROSCIENCE

Alto Neuroscience

  • Stock

USD

Last Close

4.09

22/11 21:00

Market Cap

338.20M

Beta: -

Volume Today

362.06K

Avg: -

OverviewAnalysisMetricsFinancialsFilingsAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
Dec '23
average inventory
-0.00
-
average payables
1.10M
-
1.34M
21.49%
average receivables
1.14M
-
277K
75.80%
book value per share
-0.49
-
-1.50
207.79%
-2.67
77.53%
capex per share
0.03
-
0.03
7.65%
0.02
38.92%
capex to depreciation
4.69
-
2.14
54.36%
1.26
41.13%
capex to operating cash flow
-0.07
-
-0.04
51.11%
-0.01
60.85%
capex to revenue
3.24
-
cash per share
1.01
-
1.89
88.07%
3.07
62.43%
days of inventory on hand
-0.00
-
days payables outstanding
1.51K
-
1.71K
13.48%
1.05K
38.68%
days sales outstanding
3.03K
-
debt to assets
1.33
-
1.61
21.22%
0.11
92.91%
debt to equity
-3.06
-
-2.13
30.45%
-0.14
93.53%
dividend yield
earnings yield
-0.02
-
-0.05
201.62%
-0.07
24.64%
enterprise value
541.85M
-
563.15M
3.93%
483.94M
14.07%
enterprise value over ebitda
-45.49
-
-20.58
54.77%
-14.00
31.95%
ev to operating cash flow
-58.50
-
-27.61
52.80%
-14.47
47.60%
ev to sales
2.58K
-
free cash flow per share
-0.39
-
-0.83
112.49%
-1.26
52.73%
free cash flow yield
-0.02
-
-0.04
112.49%
-0.06
52.73%
graham net net
-0.56
-
-1.58
184.06%
-2.82
77.89%
graham number
1.99
-
6.05
204.69%
9.00
48.75%
income quality
1.01
-
0.74
27.00%
0.92
25.18%
intangibles to total assets
0
-
0
0
interest coverage
-27.60
-
interest debt per share
1.49
-
3.19
114.08%
0.42
86.92%
inventory turnover
-39.84T
-
invested capital
26.93M
-
45.24M
67.96%
80.89M
78.80%
market cap
529.39M
-
529.39M
0%
556.50M
5.12%
net current asset value
-13.59M
-
-40.04M
194.67%
-72.91M
82.09%
net debt to ebitda
-1.05
-
-1.23
17.95%
2.10
270.19%
net income per share
-0.36
-
-1.08
201.62%
-1.35
24.64%
operating cash flow per share
-0.36
-
-0.80
120.19%
-1.24
56.02%
payables turnover
0.24
-
0.21
11.88%
0.35
63.09%
receivables turnover
0.12
-
research and ddevelopement to revenue
39.86
-
return on tangible assets
-0.32
-
-0.54
70.78%
-0.42
23.09%
revenue per share
0.01
-
roe
0.74
-
0.72
2.00%
0.51
29.79%
roic
-0.47
-
-0.67
43.65%
0.61
190.72%
sales general and administrative to revenue
18.55
-
shareholders equity per share
-0.49
-
-1.50
207.79%
-2.67
77.53%
stock based compensation to revenue
1.08
-
tangible asset value
-12.48M
-
-38.41M
207.79%
-71.67M
86.62%
tangible book value per share
-0.49
-
-1.50
207.79%
-2.67
77.53%
working capital
25.87M
-
43.66M
68.74%
79.78M
82.73%

All numbers in USD (except ratios and percentages)